KR Choksey recommended hold rating on Bandhan Bank with a target price of Rs 193 in its research report dated April 08, 2024. Read More KR Choksey recommended hold rating on Bandhan Bank with a target price of Rs 193… Read More »Hold Bandhan Bank; target of Rs 193: KR Choksey
The biggest loser among these stocks was HDFC Bank, declining around 6.6 percent. Other notable declines include Hindustan Unilever and Asian Paints, falling around 4.6 percent and 2.7 percent respectively. Additionally, stocks such as ITC, Axis Bank, Kotak Mahindra Bank,… Read More »Sensex @ 75,000: These stocks missed the 5,000-point run through 82 days
“At this point, you should probably take the committee and chair at face value — their best guess right now is still three cuts this year,â€� Bullard said Tuesday in an interview with Bloomberg TV. “That’s the base case.â€� Read… Read More »James Bullard says three Fed rate cuts this year is ‘base case’
Monsoon rains are expected to be 102% of the long-period average of 868.6 mm for the four-month period, Skymet said. Read More Monsoon rains are expected to be 102% of the long-period average of 868.6 mm for the four-month period,… Read More »India likely to get normal monsoon this year: Skymet
The Treasury secretary is rejecting fundamental principles to justify a policy of restricting public access to affordable and clean technology. Her plan is a protectionist disaster that will impede the path to net zero Read More The Treasury secretary is rejecting… Read More »US junks 200 years of economics to block China clean tech
The company#39;s Singapore-based step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has received approval for Fluoxetine Tabs (10 and 20 mg) from the US Food Drug Administration (USFDA), the drug firm said in a regulatory filing. Read More The company#39;s… Read More »Strides Pharma gets USFDA nod for antidepressant medication
The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company#39;s Kothur-based formulation facility. Read More The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the… Read More »Natco Pharma gets warning letter from USFDA for Telangana plant
The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside. Read More The overall range for the coming few sessions could be 22,950 on the upside and 22,550 on the downside.… Read More »FO Manual | Bulls charge indices to record highs, experts advocate buying on dips
Sharekhan is bullish on Godrej Consumer Products has recommended buy rating on the stock with a target price of Rs 1455 in its research report dated April 08, 2024. Read More Sharekhan is bullish on Godrej Consumer Products has recommended… Read More »Buy Godrej Consumer Products; target of Rs 1455: Sharekhan
The Sensex was up 382 points at 75,124.28 at open on April 9. This latest 5,000-point run in the index comes after just 82 days. Sensex had crossed the 70,000 mark in December 2023. Read More The Sensex was up… Read More »Sensex @ 75,000: Robust economy fires up Indian equities; latest run up includes most sectors
English 
हिन्दी